Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1996;22(11):1244–1249. doi: 10.1007/BF01709343

Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation

F Stéphan 1,✉, F Clergue 1, D Méhari 2, S Ricci 3, A Fajac 3, J -F Bernaudin 3
PMCID: PMC7094969  PMID: 9120120

Abstract

Objective

The study was undertaken to determine if critically ill patients under mechanical ventilation could reactivate latent cytomegalovirus (CMV) in either lung or blood.

Design

Prospective study in critically ill patients.

Setting

The study was performed in a multidisciplinary intensive care unit in a university hospital.

Patients

23 non-immunocompromised, mechanically ventilated patients who were anti-CMV immunoglobulin G-positive. Ten immunocompromised patients with active CMV infection and 16 asymptomatic CMV seropositive non-immunocompromised patients constituted the positive and negative control groups.

Measurements and results

The presence of CMV in blood and bronchoalveolar lavage (BAL) was evaluated by both viral cultures and polymerase chain reaction (PCR). Thirty-seven blood and 22 BAL samples were investigated. Sequential samples were evaluated in 8 patients. For PCR, a 290 bp fragment in the first exon of the immediate early 1 gene was amplified. In order to exclude inhibitors of PCR amplification, a 268 bp fragment of the β-globin gene was concurrently amplified in all samples. Viral cultures of blood and BAL were negative in all 23 non-immunocompromised, mechanically ventilated patients. Moreover, no CMV DNA could be amplified in blood or BAL samples, whereas a β-globin amplification was observed in all samples.

Conclusion

In a series of 23 critically ill patients under mechanical ventilation who were seropositive for CMV, no reactivation of CMV in blood or lung was demonstrated.

Key words: Cytomegalovirus, Polymerase chain reaction, Reactivation, Critically ill patients

References

  • 1.Smith CB. Cytomegalovirus pneumonia: state of the art. Chest. 1989;95:182–187. [Google Scholar]
  • 2.Alford CA, Britt WJ. Cytomegalovirus. In: Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B, editors. Virology. 2nd edn. New York: Raven Press; 1990. pp. 1981–2010. [Google Scholar]
  • 3.Domart Y, Trouillet J-L, Fagon J-Y, Chastre J, Brun-Vezinet F, Gibert C. Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest. 1990;97:18–22. doi: 10.1378/chest.97.1.18. [DOI] [PubMed] [Google Scholar]
  • 4.Döcke WD, Prösch S, Fietze E, Kimel V, Zuckermann H, Klug C, Syrbe U, Krüger DH, Von Baehr R, Volk HD. Cytomegalovirus reactivation and tumour necrosis factor. Lancet. 1994;343:268–269. doi: 10.1016/s0140-6736(94)91116-9. [DOI] [PubMed] [Google Scholar]
  • 5.Schrier RD, Nelson JA, Oldstone MBA. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science. 1985;230:1048–1051. doi: 10.1126/science.2997930. [DOI] [PubMed] [Google Scholar]
  • 6.Taylor-Wiederman J, Sissons JGP, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 1991;72:2059–2064. doi: 10.1099/0022-1317-72-9-2059. [DOI] [PubMed] [Google Scholar]
  • 7.Adler SP. Transfusion-associated cytomegalovirus infections. Rev Infect Dis. 1983;5:977–993. doi: 10.1093/clinids/5.6.977. [DOI] [PubMed] [Google Scholar]
  • 8.Toorkey CB, Carrigan DR. Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J Infect Dis. 1989;160:741–750. doi: 10.1093/infdis/160.5.741. [DOI] [PubMed] [Google Scholar]
  • 9.Griffiths PD, Grundy JE. Molecular biology and immunology of cytomegalovirus. Biochem J. 1987;241:313–324. doi: 10.1042/bj2410313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Michelson S, Plotkin SA, editors. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Elsevier; 1993. [Google Scholar]
  • 11.Abraham E. Cellular and humoral immunity in the critically ill patient. In: Shoemaker WC, Ayres S, Grenvik A, Holbrook PR, Thompson WL, editors. Textbook of critical care. 2nd edn. Philadelphia: Saunders; 1989. pp. 1024–1028. [Google Scholar]
  • 12.Shibata D, Martin WJ, Appleman MD, Causey DM, Leedom JM, Arnheim N. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis. 1988;158:1185–1192. doi: 10.1093/infdis/158.6.1185. [DOI] [PubMed] [Google Scholar]
  • 13.Cassol SA, Poon MC, Pal R, Naylor MJ, Culver-James J, Bowen TJ, Russel JA, Krawetz SA, Pon RT, Hoar DI. Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipients. J Clin Invest. 1989;83:1109–1115. doi: 10.1172/JCI113990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Einsele H, Steidle M, Vallbracht T, Saal JG, Ehninger G, Muller CA. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood. 1991;77:104–1110. [PubMed] [Google Scholar]
  • 15.Zipeto D, Revello GR, Silini E, Parea M, Percivalle E, Zavattoni M, Milanesi G, Gerna G. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J Clin Microbiol. 1992;30:527–530. doi: 10.1128/jcm.30.2.527-530.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Xu W, Sundqvist V-A, Brytting M, Linde A. Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology. Scand J Infect Dis. 1993;25:311–316. doi: 10.3109/00365549309008504. [DOI] [PubMed] [Google Scholar]
  • 17.Buffone GJ, Frost A, Samo T, Demmler GJ, Cagle PT, Lawrence EC. The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria. Transplantation. 1993;56:342–347. doi: 10.1097/00007890-199308000-00017. [DOI] [PubMed] [Google Scholar]
  • 18.Eriksson B-M, Brytting M, Zweygberg-Wirgart B, Hillerdal G, Olding-Stenkvist E, Linde A. Diagnosis of cytomegalovirus in bronchoalveolar lavage by polymerase chain reaction, in comparison with virus isolation and detection of viral antigen. Scand J Infect Dis. 1993;25:421–427. doi: 10.3109/00365549309008522. [DOI] [PubMed] [Google Scholar]
  • 19.Fajac A, Vidaud M, Lebargy F, Stephan F, Ricci S, Geslin P, Goossens M, Bernaudin J-F. Evaluation of human cytomegalovirus latency in alveolar macrophages. Am J Respir Crit Care Med. 1994;149:495–499. doi: 10.1164/ajrccm.149.2.8306052. [DOI] [PubMed] [Google Scholar]
  • 20.Hennighausen L, Fleckhenstein B. Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J. 1986;5:1367–1371. doi: 10.1002/j.1460-2075.1986.tb04368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Paya CV, Wold AD, Smith TF. Detection of cytomegalovirus infections in specimens other than urine by shell vial assay and conventional tube cell cultures. J Clin Microbiol. 1987;25:755–757. doi: 10.1128/jcm.25.5.755-757.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.McCabe WR, Jackson GG. Gramnegative bacteria I. Etiology and ecology. Arch Intern Med. 1962;110:847–864. [PubMed] [Google Scholar]
  • 23.Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;18:818–829. [PubMed] [Google Scholar]
  • 24.Murray JF, Matthay A, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1988;138:720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  • 25.Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med. 1989;17:389–393. [PubMed] [Google Scholar]
  • 26.Higuchi R. Simple and rapid preparation of samples for PCR. In: Erlich HA, editor. PCR technology: principles and applications for DNA amplification. New York: Stockton Press; 1989. pp. 31–38. [Google Scholar]
  • 27.Pritchett RF. DNA nucleotide sequence heterogeneity between the Towne and AD 169 strains of cytomegalovirus. J Virol. 1980;36:162–171. doi: 10.1128/jvi.36.1.152-161.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Saiki RK, Sharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350–1354. doi: 10.1126/science.2999980. [DOI] [PubMed] [Google Scholar]
  • 29.Sun X, Iles M, Weissman C. Physiologic variables and fluid resuscitation in the postoperative intensive care unit patient. Crit Care Med. 1993;21:555–561. doi: 10.1097/00003246-199304000-00017. [DOI] [PubMed] [Google Scholar]
  • 30.Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771–778. doi: 10.7326/0003-4819-119-8-199310150-00001. [DOI] [PubMed] [Google Scholar]
  • 31.Adler SP, Baggett J, Mc Voy M. Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. Lancet. 1985;II:743–746. doi: 10.1016/s0140-6736(85)90628-2. [DOI] [PubMed] [Google Scholar]
  • 32.Grundy JE, Super M, Sweny P, Moorhead J, Lui SF, Berry NJ, Fernando ON, Griffiths PD. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet. 1988;II:132–135. doi: 10.1016/s0140-6736(88)90685-x. [DOI] [PubMed] [Google Scholar]
  • 33.Van der Salm TJ. Cytomegalovirus: more dangerous to the cardiac surgical patient than we thought? Chest. 1990;97:3–4. doi: 10.1378/chest.97.1.3. [DOI] [PubMed] [Google Scholar]
  • 34.Gilbert GL, Hudson IL, Hayes K, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet. 1989;I:1228–1231. doi: 10.1016/s0140-6736(89)92330-1. [DOI] [PubMed] [Google Scholar]

Articles from Intensive Care Medicine are provided here courtesy of Nature Publishing Group

RESOURCES